Liprolog Mix50 Kwikpen

Insulin lispro, the active ingredient in Liprolog Mix50 Kwikpen, is a rapid‑acting insulin analog presented as a prefilled Kwikpen pen for subcutaneous use. It mimics natural insulin to control post‑prandial blood glucose in adults and children with type 1 or type 2 diabetes mellitus.

GNH USA supplies Liprolog Mix50 Kwikpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Insulin lispro is a rapid‑acting insulin analog used to manage blood glucose in diabetes mellitus.

Type 1 diabetes mellitus: provides mealtime glucose control to reduce post‑prandial hyperglycaemia. Type 2 diabetes mellitus: improves post‑prandial glycaemia when used with basal insulin or oral agents. Pediatric diabetes (children with type 1): enables flexible dosing around meals for tighter glucose management.

Common Side Effects: - Hypoglycaemia: symptoms such as sweating, tremor, or confusion. - Injection site pain or erythema. - Lipodystrophy: localized fat tissue changes. - Weight gain: due to improved glucose utilisation. - Local allergic reactions: mild rash or itching. - Edema: mild peripheral swelling.

Serious or Rare Side Effects: - Severe hypoglycaemia requiring assistance. - Anaphylactic reaction: difficulty breathing, swelling of face or throat. - Diabetic ketoacidosis if insulin therapy is abruptly stopped. - Hypokalemia: low potassium levels. - Insulin antibody formation. - Stevens‑Johnson syndrome (very rare).

Insulin lispro requires individualized dose adjustment based on glucose monitoring and carbohydrate intake.

Hypoglycaemia risk: monitor blood glucose regularly and treat low levels promptly. Renal impairment: may need lower doses due to reduced clearance. Pregnancy: use only if benefits outweigh potential risks. Driving/operating machinery: ensure stable glucose levels before engaging in activities. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulin lispro may interact with several medications that affect blood glucose.

Major Interactions (Avoid): - Beta‑blockers: can mask hypoglycaemia symptoms. - Monoamine oxidase inhibitors (MAOIs): may potentiate hypoglycaemia. - Alcohol: can cause unpredictable glucose fluctuations.

Moderate Interactions (Monitor Closely): - Oral hypoglycaemic agents (e.g., sulfonylureas, meglitinides): increased risk of hypoglycaemia. - Thiazide diuretics: may raise blood glucose levels. - Corticosteroids: may increase insulin requirements.